Immunoproliferative small intestinal disease (IPSID) occurs predominantly, but not exclusively, in the Middle East, and is characterised by diarrhoea, weight loss, abdominal pain and finger clubbing. '2 The pathological basis of these features is a heavy plasmacytic or lymphoplasmacytic infiltrate of the upper small intestinal mucosa and related mesenteric lymph nodes. In most, if not all, cases these plasma cells synthesise, without necessarily secreting,3 an abnormal a, immunoglobulin heavy chain (a chain disease). Malignant intestinal lymphoma (Mediterranean lymphoma) often arises in the setting of IPSID and opinions are divided as to whether IPSID is a malignant proliferation de novo or whether the onset of Mediterranean lymphoma represents a complication of a benign disorder.'24 The latter view is supported by the evident response of some cases of uncomplicated IPSID to broad spectrum antibiotics' 245 while cases of Mediterranean lymphoma require more radical treatment. Decisions regarding treatment are based on the interpretation of the histology of intestinal biopsy specimens.' The histopathological differential diagnosis between uncomplicated IPSID and Mediterranean lymphoma can, however, be extremely difficult and is subject to sampling error.
Central to the argument on the nature of the lymphoproliferation in IPSID, and hence the optimum Accepted for publication 2 June 1987 choice of treatment, is the clonality of the mucosal plasma cell infiltrate in the early stages of the disease. The absence of light chains and the loss of the variable region of the abnormal cxl heavy chain precludes the use of the two most common criteria of monoclonality: light chain restriction and monoclonal idiotype expression. Although cases showing light chain restriction have been described,6 7 these were in established cases of Mediterranean lymphoma rather than in examples of early IPSID. Accordingly, we analysed the DNA from three cases of IPSID for evidence of monoclonal rearrangements of both heavy and light chain immunoglobulin genes. Two cases were examples of early IPSID that had responded to conservative treatment and one was of established Mediterranean lymphoma. All three patients were from the Cape region of South Africa, where IPSID is a well recognised disease. Standard formalin fixed, paraffin embedded sections from the full thickness jejunal and mesenteric lymph node biopsy specimens were prepared and stained with haematoxylin and eosin. Immunohistochemistry was performed on these and on cryostat sections prepared from fresh tissue, snap frozen in liquid nitrogen. Sections were stained with antibodies to all immunoglobulin heavy and light chain and selected B cell and T cell antigens.
Frozen sections were prepared from tissue snap frozen in liquid nitrogen to check that the tissue being submitted for DNA analysis was representative. After Smith, Price, Isaacson collection in edetic acid, lymphocytes from peripheral blood from all three patients were separated on a Ficoll hypaque gradient, harvested, and snap frozen in liquid nitrogen. High molecular weight DNA was extracted by standard methods from the biopsy specimens and peripheral blood lymphocytes.8 After digestion with HindlIl, EcoRI, BamHl, and BglII restriction enzymes the fragments were separated according to size on an agarose gel by electrophoresis and Southern blots9 prepared using Gene Screen Plus filters (DuPont). Table 1 details the recombinant DNA probes used and their sources. They were radiolabelled with 32P-dCTP by the random hexanucleotide method10 and hybridised to the filters under conditions recommended by the manufacturer. After stringent washing the filters were exposed to pre-fogged x-ray film.
Results
The histological appearances (table 2) of the biopsy specimens in cases 1 and 2 showed a dense plasma cell infiltrate confined by the muscularis mucosae. This was focal in case 1, whose biopsy specimen also showed lymphoepithelial lesions,' 1 and diffuse in case 2. The lymph node of case 1 showed reactive hyperplasia while that of case 2 showed infiltration with mature plasma cells. The small intestinal biopsy specimen of case 3 showed a nodular mucosal lymphoplasmacytic infiltrate which breached the muscularis mucosae. Lymphoepithelial lesions were 'present; lymph node architecture was effaced by a similar infiltrate.
Immunohistochemistry of paraffin sections showed Interpretation of the data obtained with the CA probe was complicated by the nature of the locus: it is highly polymorphic and composed of between six and nine genes per haploid genome. 6 Comparison of the patterns obtained from the DNA purified from the biopsy specimens with that extracted from the peripheral blood lymphocytes suggested that rearrangement of this complex locus had occurred in biopsy specimens from all three patients. If no rearrangement had occurred it could be predicted that the patterns obtained from the tissue would be identical with that in peripheral blood leucocytes which showed no evidence of clonal rearrangements.
The demonstration of rearrangement in the A light chain loci in cases 1 and 3, despite the lack of immunohistochemical evidence for synthesis of A light chain, can be interpreted in several ways. The first possibility is that A chains were present at the cell surface but only at levels not detectable by immunohistochemistry. The second is that both light and heavy Ig genes were correctly transcribed and translated, but that the assembly of the complete molecule or its transport to the membrane was impaired. Alter transcribed or translated. The analysis of light chain genes in case 2, whose tumour showed K light chain restriction, showed the unusual, but not unprecedented, evidence of both K and A rearrangements.202' Histopathologists recognise three stages of IPSID.'
In the first stage (A) a benign appearing plasma cell or lympohoplasmacytic infiltrate is confined to the mucosa and mesenteric lymph nodes. In stage B cytologically neoplastic cells begin to appear in this infiltrate which extends into the submucosa and beyond, while in stage C there is frank recognisable lymphoma. Patients in stage A may respond to antibiotics alone (as is well shown by case I in this report, and, to a lesser extent, by case 2). The pathology in case 3 is that of stage B and his failure to respond to conservative treatment was expected. In view of the response of some patients to antibiotics seems to be responding normally to a stimulus of lumenal bacterial overgrowth and involuting when this stimulus is removed by broad spectrum antibiotics. Claims of "cure" using antibiotics alone should be treated with caution as IPSID can have a long natural history before lymphomatous masses become evident, and relapses after an initial response to antibiotics are common. 4 In view of our findings should all cases of IPSID receive chemotherapy or radiotherapy regardless of stage? Unless one can be certain that this form of treatment will destroy the malignant clone, it is probably wise to withhold it until such time as antibiotics fail to control the disease. Newer forms of treatment for lymphoid malignancy, possibly immunologically based, however, must surely emerge and the knowledge that IPSID is a neoplasm de novo is important to keep in mind in Studies on animals have shown that mucosal plasma cells are derived from Peyers patch lymphocytes indirectly via the mucosal lymphatics and the circulation. 23 We therefore might have expected to detect a monoclonal population of cells in the circulation in our cases, especially in cases 2 and 3 with active disease. Such clones have indeed been detected by Southern blotting in cases of low grade nodal nonHodgkin's lymphoma, including cases in remission. 24 In view of our findings and as the evidence for the circulatory phase of gut associated lymphoid tissue is entirely animal derived, its presence in man should perhaps be questioned.
The epidemiology of IPSID together with reports of specific HLA association25 26 points to a genetic predisposition in this disease, which when combined with one or more environmental factors leads to abnormal IgA synthesis and lymphoma. The use of further molecular techniques together with cytogenetic studies of patients and their families is indicated to elucidate the molecular biology of IPSID.
The findings of such a study would be relevant not only to IPSID, but to the pathogenesis of B cell lymphoma as a whole.
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